Splinter Cell film moving forward

New Regency producing big-screen version of Ubisoft's stealth action series with Tom Hardy as Sam Fisher.

Comments

Related
Tom Clancy's Splinter Cell: Blacklist
Follow

New Regency will produce the film adaptation of Ubisoft's Splinter Cell franchise, according to a press release at Deadline. As was previously announced, Inception and The Dark Knight Rises star Tom Hardy will play the role of Sam Fisher, with Eric Warren Singer (The International) attached to write the script.

No Caption Provided

Details on the Splinter Cell film's plot remain a mystery, though Ubisoft Motion Pictures chief executive officer Jean-Julien Baronnet said in a statement that the partnership will allow the publisher to have "creative freedom." Additionally, he said New Regency shares Ubisoft's "commitment to respecting the creative freedom of our team," thus making the studio an "ideal fit" for the project.

This is not the first partnership between New Regency and Ubisoft Motion Pictures. The companies are also working together to bring Assassin's Creed to the silver screen, possibly as early as next year. Inglourious Basterds and Shame star Michael Fassbender will play the lead role in that film.

New Regency is a division of Regency Enterprises. Past projects produced by the company include Mr. and Mrs. Smith and Marly & Me. The company is producing Darren Aronofsky's upcoming biblical epic Noah, as well as Twelve Years a Slave.

Splinter Cell: Blacklist is the next entry in Ubisoft's long-running stealth action series. It is due out next year for the Xbox 360, PlayStation 3, and PC. For more on that game, check out GameSpot's previous coverage.

Please use a html5 video capable browser to watch videos.
This video has an invalid file format.
00:00:00
Sorry, but you can't access this content!
Please enter your date of birth to view this video

By clicking 'enter', you agree to GameSpot's
Terms of Use and Privacy Policy

Got a news tip or want to contact us directly? Email news@gamespot.com

  •   View Comments (0)
    Join the conversation
    There are no comments about this story